Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TOST vs MRNA✓SelectedUSD · MRNATOST vs MRNA performance historyLatest closeAs of+1.04%11/18
Stock and ETF performance explorer

TOST vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-24.6%
MRNA return
-25.9%
Excess return
+1.3%
Maximum drawdown
-71.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.0%-4.8%+5.9%+1.4%
7D-0.3%-20.9%+20.6%+1.6%
30D+8.1%-13.3%+21.4%+9.0%
3M-2.7%+212.6%-215.3%-18.7%
6M+50.2%+309.0%-258.9%+16.7%
YTD-4.3%+567.3%-571.6%-35.8%
1Y+0.8%+689.7%-688.9%-35.5%
3Y+136.1%+157.4%-21.3%+79.3%
All-24.6%-25.9%+1.3%-27.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling